Independent Laboratory Billing of Laboratory Tests for End-Stage Renal Disease (ESRD) Beneficiaries and the Sunset of the CB Modifier CR11061 Feb 05, 2019

Independent Laboratory Billing of Laboratory Tests for End-Stage Renal Disease (ESRD) Beneficiaries and the Sunset of the CB Modifier.

MLN Matters Number: MM11061
Related CR Release Date: February 1, 2019
Related CR Transmittal Number: R4227CP
Related Change Request (CR) Number: 11061
Effective Date: July 1, 2019
Implementation Date: July 1, 2019

Change Request (CR) 11061 sunsets the requirement for Independent Laboratories to use the CB modifier to bill separately for renal dialysis laboratory tests. Make sure your billing staff is aware of these changes.

Source: https://med.noridianmedicare.com/web/jeb/article-detail/-/view/10525/independent-laboratory-billing-of-laboratory-tests-for-end-stage-renal-disease-esrd-beneficiaries-and-the-sunset-of-the-cb-modifier